The Food and Drug Administration approved Chelsea Therapeutics International Ltd.’s (Nasdaq: CHTP) low blood pressure treatment Northera sending the stock price soaring $1.34 to $6.29.
FDA Approves Northera
February 19, 2014 at 05:03 AM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.